View:
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BioTime, Inc.
(Exact name of registrant as specified in its charter)
California
(State of incorporation or organization)
94-3127919
(I.R.S. Employer Identification No.)
935 Pardee Street, Berkeley, California 94710
(Address of Principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
None
If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to
General Instruction A.(c), check the following box. [ ]
If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to
General Instruction A.(d), check the following box. [x]
Securities Act registration statement file number to which this
form relates: ________
(if applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
Common Shares, no par value
(Title of Class)
1
Item 1. Description of Registrant's Securities to be Registered.
Common Shares
Each holder of record of Common Shares is entitled to one vote for each
outstanding Common Share owned by him on every matter properly submitted to the
shareholders for their vote.
The Common Shares have no preference as to dividends. Subject to the
dividend rights of any of the preferred shares that may be issued from time to
time, holders of Common Shares are entitled to any dividend declared by the
Board of Directors out of funds legally available for such purpose.
The Common Shares have no preference as to liquidation. Subject to the
prior payment of liquidation preference to holders of any preferred shares that
may be issued, holders of Common Shares are entitled to receive on a prorata
basis all remaining assets of the Company available for distribution to the
holders of Common Shares in the event of the liquidation, dissolution, or
winding up of the Company. Holders of Common Shares do not have any preemptive
rights to become subscribers or purchasers of additional shares of any class of
the Company's capital stock.
The Common Shares have no restriction on alienability.
Item 2. Exhibits.
1. A copy of the certificate for the security being registered is included
as Exhibit 4(a) to Registrant's Registration Statement on Form S-1, No.
33-44549, filed with the Commission on December 18, 1991, and Amendment
No. 1 and Amendment No. 2 thereto filed with the Securities and
Exchange Commission on February 6, 1992 and March 7, 1992,
respectively, which exhibit is incorporated herein by reference.
2. Articles of Incorporation, as amended, are included as Exhibit 3.1 of
Registrant's Annual Report on Form 10-K for the fiscal year ended June
30, 1997 filed with the Securities and Exchange Commission, which
exhibit is incorporated herein by reference..
3. Bylaws, as amended, are included as Exhibit 3(c) to Registrant's
Registration Statement on Form S-1, No. 33-48717 and Post-Effective
Amendment No. 1 thereto, filed with the Securities and Exchange
Commission on June 22, 1992 and August 27, 1992, respectively, which
exhibit is incorporated herein by reference.
2
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Date April 23, 1998 BioTime, Inc.
By: /s/Paul Segall
---------------------------------------
Paul Segall, Chief Executive Officer
3